UFP Technologies Announces Record Q2 Results
UFP Technologies, Inc. (Nasdaq: UFPT), a trusted contract development and manufacturing organization specializing in comprehensive solutions for medical devices, sterile packaging and other highly engineered custom products, today reported net income of $20.9 million for its second quarter ended June 30, 2026, 21.4% higher than net income of $17.2 million for the second quarter of 2025. Net sales for the quarter ended June 30, 2026 were $174.0 million, 15.1% higher than 2025 second quarter sales of $151.2 million. Generally accepted accounting principles ("GAAP") and adjusted earnings per diluted common share outstanding ("EPS") for the quarter ended June 30, 2026 were $2.68 and $2.92, respectively. Net sales, net income, and EPS for the second quarter of 2026 reflect record quarterly results for the Company. Net income for the six-month period ended June 30, 2026 was $38.3 million, 11.6% higher than net income of $34.4 million for the same period in 2025. Net sales for the six-month period ended June 30, 2026 were $328.2 million, compared to sales of $299.3 million in the same period of 2025. GAAP and adjusted EPS for the six-month period ended June 30, 2026 were $4.92 and $5.39, respectively.
